BMRA
Biomerica·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
Ample Liquidity
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BMRA
Biomerica, Inc.
A global biomedical technology company that focused on medical diagnostic products designed to detect chronic diseases
Healthcare Equipment and Supplies
Invalid Date
08/26/2016
NASDAQ Stock Exchange
53
05-31
Common stock
17571 Von Karman Avenue, Irvine, CA 92614
--
Biomerica, Inc., was incorporated in Delaware in September 1971 as Nuclear Medical Systems, Inc., and later changed its name to Biomerica, Inc. The company has two wholly-owned subsidiaries: Biomerica de Mexico, for assembly or manufacturing, and BioEurope GmbH, as a distributor of Biomerica products in certain markets. The Company is a global biomedical technology company that develops, applies for patents, manufactures and markets advanced diagnostic and therapeutic products for use in medical points (home and doctor's office) and hospital/clinical laboratories for the detection and treatment of medical conditions and diseases.
Company Financials
EPS
BMRA has released its 2024 Q3 earnings. EPS was reported at -0.11, versus the expected 0, missing expectations. The chart below visualizes how BMRA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BMRA has released its 2026 Q1 earnings report, with revenue of 1.38M, reflecting a YoY change of -23.63%, and net profit of 2.00K, showing a YoY change of 100.15%. The Sankey diagram below clearly presents BMRA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
